Subscribe to Newsletter

Retina

Subspecialties Cataract

Rupture Risk

| Ruth Steer

Mounting evidence suggests intravitreal injections increase risk of PCR during cataract surgery – why?

Subspecialties Retina

Peptide Power

| Ruth Steer

Could a small biomimetic peptide be a promising alternative to anti-VEGF treatment?

Subspecialties Basic & Translational Research

Benchmarking Dry AMD

| Roisin McGuigan

What does analysis of the last five years of dry AMD literature tell us about the field?

Subspecialties Business and Innovation

The Bot that Busts Clots

| Ruth Steer

A world first: clinical use of a robot for retinal vein cannulation.

Subspecialties Other

Tears of Blood

| Mark Hillen

Are new ocular anticoagulants more or less likely than warfarin to cause intraocular bleeding?

Business & Profession Business and Innovation

OCT for all, and all for OCT

| Mark Hillen

Eye exams can detect more than ocular disease - is there a place in general practice for OCT?

Subspecialties Health Economics and Policy

What Does a Trump Presidency Mean for Obamacare?

| Brian Joondeph

Repeal and replace - what does it actually mean for eyecare?

Business & Profession Basic & Translational Research

Image of the Month

An artistic simulation of sight with AMD.

Subspecialties Retina

No Synergy

| Ruth Steer

Is pegpleranib + ranibizumab better than ranibizumab alone? Phase III results suggest not…

Subspecialties Retina

Same Difference

| Ruth Steer

Real-world observational study comparing ranibizumab and aflibercept shows similar outcomes.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.